- Safety & Recalls
- Regulatory Updates
- Drug Coverage
- COPD
- Cardiovascular
- Obstetrics-Gynecology & Women's Health
- Ophthalmology
- Clinical Pharmacology
- Pediatrics
- Urology
- Pharmacy
- Idiopathic Pulmonary Fibrosis
- Diabetes and Endocrinology
- Allergy, Immunology, and ENT
- Musculoskeletal/Rheumatology
- Respiratory
- Psychiatry and Behavioral Health
- Dermatology
- Oncology
Low back pain may be difficult to self-manage, study says
Self-management has small effects on pain and disability in people with low back pain, according to a study published online in Arthritis Care & Research.
Self-management has small effects on pain and disability in people with low back pain, according to a study published online in Arthritis Care & Research.
“We found very few trials that tested self-management for low back pain, and in many of the trials we had some concerns about the adequacy of the self-management programs that were tested,” Vinicius Cunha Oliveira, PhD candidate, Arthrithis & Musculoskeletal Research Group, The University of Sydney, Australia, told Formulary. “Acknowledging those limitations, the effects of self-management on pain and disability seemed small, questioning whether or not it is a worthwhile approach.
“There is a growing awareness that low back pain is a long-term condition and that self-management can potentially decrease the burden of this condition,” Oliveira continued. “However, evidence of the effectiveness of self-management of low back pain was unclear.”
Oliveira and colleagues performed a systemic review searching the Medline, Embase, CINAHL, PsycINFO, LILACS, PEDro, AMED, SPORTDIScus, and Cochrane databases from the earliest record to April 2011, that included participants with low back pain of any duration. The researchers included trials in which at least 1 intervention for low back pain was named as “self-management” or “self-care.” Eligible studies were assessed for methodological quality using the PEDro scale, and the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system was used to summarize the strength of the recommendation for each outcome.
The weighted mean difference at short-term follow-up for pain was -3.2 points on a 0–100 scale (95% CI, -5.1, -1.3) and for disability was -2.3 points (95% CI, -3.7, -1.0). The long-term effects were -4.8 (95% CI, -7.1, -2.5) for pain and -2.1 (95% CI, -3.6, -0.6) for disability.
THE FIRST REVIEW
“This was the first review in this area,” he said. “The findings challenge endorsement of self-management for low back pain. Unfortunately, self-management does not help much in low back pain.
“We caution that it would be premature to completely dismiss self-management. We recommend establishing the definition of self-management for low back pain as well as the features of self-management programs by consensus. Research should further understand self-management for low back pain and if specific features may increase its effectiveness.” â
For more on low back pain, go to http://www.ncbi.nlm.nih.gov/pubmed/22623349
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.
